Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2

Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous ( iv ) administration provides s...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 14; no. 1; pp. 8229 - 16
Main Authors Hilligan, Kerry L., Namasivayam, Sivaranjani, Clancy, Chad S., Baker, Paul J., Old, Samuel I., Peluf, Victoria, Amaral, Eduardo P., Oland, Sandra D., O’Mard, Danielle, Laux, Julie, Cohen, Melanie, Garza, Nicole L., Lafont, Bernard A. P., Johnson, Reed F., Feng, Carl G., Jankovic, Dragana, Lamiable, Olivier, Mayer-Barber, Katrin D., Sher, Alan
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 12.12.2023
Nature Publishing Group
Nature Portfolio
Subjects
13/1
13/106
13/21
13/31
14/63
38/32
38/91
631/250/127/1212
631/326/596/2553
631/326/596/4130
64/60
Animal models
Animals
Antiviral agents
Bacteria
Bacterial diseases
Bacterial infections
Bronchopulmonary infection
COVID-19
COVID-19 - prevention & control
Epithelial cells
Epithelium
Hematopoietic stem cells
Humanities and Social Sciences
Immunity
Infections
Interferon
Interferon Type I - pharmacology
Interferon-gamma
Lung
Lungs
Mice
multidisciplinary
Pathogenesis
SARS-CoV-2
Science
Science (multidisciplinary)
Severe acute respiratory syndrome coronavirus 2
Viral diseases
γ-Interferon
Online AccessGet full text

Cover

Abstract Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous ( iv ) administration provides strong protection against SARS-CoV-2 in mice yet drives low levels of type-1 IFNs but robust IFNγ. Here we examine the role of ongoing IFNγ responses to pre-established bacterial infection on SARS-CoV-2 disease outcomes in two murine models. We report that IFNγ is required for iv BCG induced reduction in pulmonary viral loads, an outcome dependent on IFNγ receptor expression by non-hematopoietic cells. Importantly, we show that BCG infection prompts pulmonary epithelial cells to upregulate IFN-stimulated genes with reported anti-viral activity in an IFNγ-dependent manner, suggesting a possible mechanism for the observed protection. Finally, we confirm the anti-viral properties of IFNγ by demonstrating that the recombinant cytokine itself provides strong protection against SARS-CoV-2 challenge when administered intranasally. Together, our data show that a pre-established IFNγ response within the lung is protective against SARS-CoV-2 infection, suggesting that concurrent or recent infections that drive IFNγ may limit the pathogenesis of SARS-CoV-2 and supporting possible prophylactic uses of IFNγ in COVID-19 management. The role of interferon-γ (IFNγ) in anti-viral immunity has been unclear. Here the authors show that bacterial-induced or intranasally administered IFNγ effectively restricts SARS-CoV-2 infection in mice through effects on non-hematopoietic cells.
AbstractList Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous ( iv ) administration provides strong protection against SARS-CoV-2 in mice yet drives low levels of type-1 IFNs but robust IFNγ. Here we examine the role of ongoing IFNγ responses to pre-established bacterial infection on SARS-CoV-2 disease outcomes in two murine models. We report that IFNγ is required for iv BCG induced reduction in pulmonary viral loads, an outcome dependent on IFNγ receptor expression by non-hematopoietic cells. Importantly, we show that BCG infection prompts pulmonary epithelial cells to upregulate IFN-stimulated genes with reported anti-viral activity in an IFNγ-dependent manner, suggesting a possible mechanism for the observed protection. Finally, we confirm the anti-viral properties of IFNγ by demonstrating that the recombinant cytokine itself provides strong protection against SARS-CoV-2 challenge when administered intranasally. Together, our data show that a pre-established IFNγ response within the lung is protective against SARS-CoV-2 infection, suggesting that concurrent or recent infections that drive IFNγ may limit the pathogenesis of SARS-CoV-2 and supporting possible prophylactic uses of IFNγ in COVID-19 management.
Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous ( iv ) administration provides strong protection against SARS-CoV-2 in mice yet drives low levels of type-1 IFNs but robust IFNγ. Here we examine the role of ongoing IFNγ responses to pre-established bacterial infection on SARS-CoV-2 disease outcomes in two murine models. We report that IFNγ is required for iv BCG induced reduction in pulmonary viral loads, an outcome dependent on IFNγ receptor expression by non-hematopoietic cells. Importantly, we show that BCG infection prompts pulmonary epithelial cells to upregulate IFN-stimulated genes with reported anti-viral activity in an IFNγ-dependent manner, suggesting a possible mechanism for the observed protection. Finally, we confirm the anti-viral properties of IFNγ by demonstrating that the recombinant cytokine itself provides strong protection against SARS-CoV-2 challenge when administered intranasally. Together, our data show that a pre-established IFNγ response within the lung is protective against SARS-CoV-2 infection, suggesting that concurrent or recent infections that drive IFNγ may limit the pathogenesis of SARS-CoV-2 and supporting possible prophylactic uses of IFNγ in COVID-19 management. The role of interferon-γ (IFNγ) in anti-viral immunity has been unclear. Here the authors show that bacterial-induced or intranasally administered IFNγ effectively restricts SARS-CoV-2 infection in mice through effects on non-hematopoietic cells.
Abstract Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous (iv) administration provides strong protection against SARS-CoV-2 in mice yet drives low levels of type-1 IFNs but robust IFNγ. Here we examine the role of ongoing IFNγ responses to pre-established bacterial infection on SARS-CoV-2 disease outcomes in two murine models. We report that IFNγ is required for iv BCG induced reduction in pulmonary viral loads, an outcome dependent on IFNγ receptor expression by non-hematopoietic cells. Importantly, we show that BCG infection prompts pulmonary epithelial cells to upregulate IFN-stimulated genes with reported anti-viral activity in an IFNγ-dependent manner, suggesting a possible mechanism for the observed protection. Finally, we confirm the anti-viral properties of IFNγ by demonstrating that the recombinant cytokine itself provides strong protection against SARS-CoV-2 challenge when administered intranasally. Together, our data show that a pre-established IFNγ response within the lung is protective against SARS-CoV-2 infection, suggesting that concurrent or recent infections that drive IFNγ may limit the pathogenesis of SARS-CoV-2 and supporting possible prophylactic uses of IFNγ in COVID-19 management.
Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous (iv) administration provides strong protection against SARS-CoV-2 in mice yet drives low levels of type-1 IFNs but robust IFNγ. Here we examine the role of ongoing IFNγ responses to pre-established bacterial infection on SARS-CoV-2 disease outcomes in two murine models. We report that IFNγ is required for iv BCG induced reduction in pulmonary viral loads, an outcome dependent on IFNγ receptor expression by non-hematopoietic cells. Importantly, we show that BCG infection prompts pulmonary epithelial cells to upregulate IFN-stimulated genes with reported anti-viral activity in an IFNγ-dependent manner, suggesting a possible mechanism for the observed protection. Finally, we confirm the anti-viral properties of IFNγ by demonstrating that the recombinant cytokine itself provides strong protection against SARS-CoV-2 challenge when administered intranasally. Together, our data show that a pre-established IFNγ response within the lung is protective against SARS-CoV-2 infection, suggesting that concurrent or recent infections that drive IFNγ may limit the pathogenesis of SARS-CoV-2 and supporting possible prophylactic uses of IFNγ in COVID-19 management.Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous (iv) administration provides strong protection against SARS-CoV-2 in mice yet drives low levels of type-1 IFNs but robust IFNγ. Here we examine the role of ongoing IFNγ responses to pre-established bacterial infection on SARS-CoV-2 disease outcomes in two murine models. We report that IFNγ is required for iv BCG induced reduction in pulmonary viral loads, an outcome dependent on IFNγ receptor expression by non-hematopoietic cells. Importantly, we show that BCG infection prompts pulmonary epithelial cells to upregulate IFN-stimulated genes with reported anti-viral activity in an IFNγ-dependent manner, suggesting a possible mechanism for the observed protection. Finally, we confirm the anti-viral properties of IFNγ by demonstrating that the recombinant cytokine itself provides strong protection against SARS-CoV-2 challenge when administered intranasally. Together, our data show that a pre-established IFNγ response within the lung is protective against SARS-CoV-2 infection, suggesting that concurrent or recent infections that drive IFNγ may limit the pathogenesis of SARS-CoV-2 and supporting possible prophylactic uses of IFNγ in COVID-19 management.
Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous (iv) administration provides strong protection against SARS-CoV-2 in mice yet drives low levels of type-1 IFNs but robust IFNγ. Here we examine the role of ongoing IFNγ responses to pre-established bacterial infection on SARS-CoV-2 disease outcomes in two murine models. We report that IFNγ is required for iv BCG induced reduction in pulmonary viral loads, an outcome dependent on IFNγ receptor expression by non-hematopoietic cells. Importantly, we show that BCG infection prompts pulmonary epithelial cells to upregulate IFN-stimulated genes with reported anti-viral activity in an IFNγ-dependent manner, suggesting a possible mechanism for the observed protection. Finally, we confirm the anti-viral properties of IFNγ by demonstrating that the recombinant cytokine itself provides strong protection against SARS-CoV-2 challenge when administered intranasally. Together, our data show that a pre-established IFNγ response within the lung is protective against SARS-CoV-2 infection, suggesting that concurrent or recent infections that drive IFNγ may limit the pathogenesis of SARS-CoV-2 and supporting possible prophylactic uses of IFNγ in COVID-19 management.The role of interferon-γ (IFNγ) in anti-viral immunity has been unclear. Here the authors show that bacterial-induced or intranasally administered IFNγ effectively restricts SARS-CoV-2 infection in mice through effects on non-hematopoietic cells.
Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous (iv) administration provides strong protection against SARS-CoV-2 in mice yet drives low levels of type-1 IFNs but robust IFNγ. Here we examine the role of ongoing IFNγ responses to pre-established bacterial infection on SARS-CoV-2 disease outcomes in two murine models. We report that IFNγ is required for iv BCG induced reduction in pulmonary viral loads, an outcome dependent on IFNγ receptor expression by non-hematopoietic cells. Importantly, we show that BCG infection prompts pulmonary epithelial cells to upregulate IFN-stimulated genes with reported anti-viral activity in an IFNγ-dependent manner, suggesting a possible mechanism for the observed protection. Finally, we confirm the anti-viral properties of IFNγ by demonstrating that the recombinant cytokine itself provides strong protection against SARS-CoV-2 challenge when administered intranasally. Together, our data show that a pre-established IFNγ response within the lung is protective against SARS-CoV-2 infection, suggesting that concurrent or recent infections that drive IFNγ may limit the pathogenesis of SARS-CoV-2 and supporting possible prophylactic uses of IFNγ in COVID-19 management.
ArticleNumber 8229
Author Feng, Carl G.
Old, Samuel I.
Baker, Paul J.
Johnson, Reed F.
Mayer-Barber, Katrin D.
Garza, Nicole L.
Hilligan, Kerry L.
Laux, Julie
Clancy, Chad S.
Peluf, Victoria
Cohen, Melanie
O’Mard, Danielle
Jankovic, Dragana
Namasivayam, Sivaranjani
Amaral, Eduardo P.
Oland, Sandra D.
Lamiable, Olivier
Lafont, Bernard A. P.
Sher, Alan
Author_xml – sequence: 1
  givenname: Kerry L.
  orcidid: 0000-0003-1238-1552
  surname: Hilligan
  fullname: Hilligan, Kerry L.
  email: khilligan@malaghan.org.nz
  organization: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Malaghan Institute of Medical Research
– sequence: 2
  givenname: Sivaranjani
  orcidid: 0000-0001-9993-1347
  surname: Namasivayam
  fullname: Namasivayam, Sivaranjani
  organization: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 3
  givenname: Chad S.
  orcidid: 0000-0002-5354-9270
  surname: Clancy
  fullname: Clancy, Chad S.
  organization: Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 4
  givenname: Paul J.
  surname: Baker
  fullname: Baker, Paul J.
  organization: Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 5
  givenname: Samuel I.
  orcidid: 0000-0003-1245-4459
  surname: Old
  fullname: Old, Samuel I.
  organization: Malaghan Institute of Medical Research
– sequence: 6
  givenname: Victoria
  orcidid: 0009-0001-0793-1049
  surname: Peluf
  fullname: Peluf, Victoria
  organization: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 7
  givenname: Eduardo P.
  orcidid: 0000-0001-5465-8113
  surname: Amaral
  fullname: Amaral, Eduardo P.
  organization: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 8
  givenname: Sandra D.
  orcidid: 0000-0002-6544-5268
  surname: Oland
  fullname: Oland, Sandra D.
  organization: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 9
  givenname: Danielle
  surname: O’Mard
  fullname: O’Mard, Danielle
  organization: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 10
  givenname: Julie
  orcidid: 0000-0002-9817-3852
  surname: Laux
  fullname: Laux, Julie
  organization: Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 11
  givenname: Melanie
  orcidid: 0000-0002-4839-9386
  surname: Cohen
  fullname: Cohen, Melanie
  organization: Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 12
  givenname: Nicole L.
  surname: Garza
  fullname: Garza, Nicole L.
  organization: SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 13
  givenname: Bernard A. P.
  orcidid: 0000-0003-2140-6205
  surname: Lafont
  fullname: Lafont, Bernard A. P.
  organization: SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 14
  givenname: Reed F.
  surname: Johnson
  fullname: Johnson, Reed F.
  organization: SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 15
  givenname: Carl G.
  orcidid: 0000-0003-4301-4640
  surname: Feng
  fullname: Feng, Carl G.
  organization: Immunology and Host Defense Group, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Centenary Institute, The University of Sydney
– sequence: 16
  givenname: Dragana
  orcidid: 0000-0001-7360-1809
  surname: Jankovic
  fullname: Jankovic, Dragana
  organization: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 17
  givenname: Olivier
  orcidid: 0000-0001-7571-9253
  surname: Lamiable
  fullname: Lamiable, Olivier
  organization: Malaghan Institute of Medical Research
– sequence: 18
  givenname: Katrin D.
  orcidid: 0000-0002-0311-3233
  surname: Mayer-Barber
  fullname: Mayer-Barber, Katrin D.
  organization: Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 19
  givenname: Alan
  orcidid: 0000-0001-7053-2895
  surname: Sher
  fullname: Sher, Alan
  email: asher@niaid.nih.gov
  organization: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38086794$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1TAQhi1URC_0BVigSGzYBHxL4qxQOaJQqRISBbbWxBmf-iixD3ZSqW-P05TSssCbsTz_fOMZ_cfkwAePhLxi9B2jQr1Pksm6KSkXpRRS5tszcsSpZCVruDh4dD8kpyntaD6iZUrKF-RQKKrqppVHZP8RzITRwVA6388G-yLEYg8puRscbgvoR-ddypKccT5HizH4YgvjCIUJvneTCz4V0zUWw-y3hc31CDHX5uwUw1AEW1ydfbsqN-FnyV-S5xaGhKf38YT8OP_0ffOlvPz6-WJzdlmaSrKpbEECrWvVClqDlJazXmHD64r3XHErmVVUIjLoemp5ZSnyqqV1xZjgpuuoOCEXK7cPsNP76EaItzqA03cPIW41xMmZAXXTGsGERJBdJTk1HW9BdQKokn1nmcqsDytrP3cj9gbzXDA8gT7NeHett-FGM9qwmgmRCW_vCTH8mjFNenTJ4DCAxzAnzVvKWyEavjR78490F-bo864WFW3rjFtUfFWZGFKKaB9-w6heDKJXg-hsEH1nEL3s5PXjOR5K_tghC8QqSDnltxj_9v4P9jfa7Md3
CitedBy_id crossref_primary_10_1126_science_adl2016
crossref_primary_10_3390_ijms25042155
crossref_primary_10_3390_ijms25136917
crossref_primary_10_1128_jvi_00584_24
crossref_primary_10_3390_biomedicines12061281
crossref_primary_10_1038_s41590_023_01713_9
crossref_primary_10_1016_j_ejmech_2024_116214
crossref_primary_10_3389_fimmu_2024_1424374
crossref_primary_10_1371_journal_ppat_1012339
Cites_doi 10.1038/s42003-020-01625-6
10.1007/s00134-021-06377-3
10.1371/journal.pmed.0050026
10.1038/ni1001-907
10.1016/j.immuni.2021.06.003
10.1016/j.cell.2020.05.042
10.1016/j.cmi.2022.04.009
10.3389/fimmu.2017.00259
10.1128/JVI.72.8.6637-6645.1998
10.1016/j.cell.2020.04.035
10.1056/NEJMoa2212616
10.1371/journal.ppat.1010093
10.1128/spectrum.03075-22
10.1093/oxfordjournals.aje.a118408
10.1093/cid/ciaa1198
10.1073/pnas.2221652120
10.1038/s41586-020-2708-8
10.1016/j.cell.2020.06.010
10.1016/j.celrep.2019.11.021
10.1084/jem.178.5.1725
10.1016/j.jmoldx.2011.08.002
10.1016/j.isci.2023.107733
10.1093/infdis/jiaa030
10.1093/cid/ciaa453
10.1002/cti2.1387
10.1371/journal.ppat.1003773
10.1146/annurev.immunol.26.021607.090331
10.1016/j.cell.2020.02.052
10.3389/fimmu.2022.841868
10.1093/nar/gks1215
10.1016/j.molcel.2021.04.008
10.3389/fmed.2021.657006
10.1016/S0928-8244(03)00358-4
10.1016/j.celrep.2022.110799
10.1056/NEJMoa2209760
10.1016/j.cell.2021.04.048
10.1371/journal.ppat.1000849
10.1165/ajrcmb.17.1.f132
10.1146/annurev-virology-092818-015756
10.1056/NEJM199612263352604
10.1016/S0022-3476(99)70064-8
10.3389/fimmu.2023.1232764
10.1093/cid/ciac182
10.1371/journal.ppat.1009427
10.1002/eji.1830250331
10.3389/fimmu.2022.869809
10.1093/infdis/jis012
10.1016/j.medj.2021.09.003
10.1038/s41586-020-2012-7
10.1016/j.virol.2014.07.039
10.1038/s41586-022-04802-1
10.1002/iid3.92
10.1016/j.cell.2021.02.042
10.1128/mbio.00356-23
10.1186/s12931-015-0282-7
10.1161/01.CIR.97.10.1017
10.1084/jem.178.4.1435
10.1634/stemcells.2006-0644
10.1056/NEJM199612263352602
10.1038/s41590-020-0778-2
10.1002/eji.202249913
10.1038/s41591-020-01227-z
10.1016/j.celrep.2021.109126
10.1016/j.celrep.2017.04.031
10.1016/j.vaccine.2014.10.041
10.1038/s41392-021-00848-1
10.1038/nature06553
10.1016/j.cell.2020.09.050
10.1038/s41564-020-0769-y
10.1038/mi.2017.41
10.1016/j.celrep.2022.110502
10.1093/cid/ciac881
10.1016/j.celrep.2020.108530
10.1016/j.ijid.2023.02.014
10.1089/jir.2009.0084
10.1038/s41590-020-00840-x
10.1038/s41541-021-00406-4
10.1126/science.abc6027
10.3389/fimmu.2023.1240419
10.1084/jem.20201241
10.1084/jem.20211818
10.1128/mBio.01928-20
10.1007/978-3-319-24277-4
10.1101/2022.09.13.507852
10.1172/jci.insight.159422
10.1084/jem.20211862
10.1172/jci.insight.157393
10.3390/v14010027
10.1128/JVI.01410-20
10.1084/jem.20220621
10.2807/1560-7917.ES.2020.25.3.2000045
10.1101/2023.07.31.551354
10.1038/s41586-023-06322-y
10.1038/s41564-023-01431-w
10.36233/0507-4088-24
ContentType Journal Article
Copyright This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 2023
2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023.
This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 2023
– notice: 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023.
– notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PIMPY
PQEST
PQQKQ
PQUKI
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-023-43447-0
DatabaseName SpringerOpen
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
Health Research Premium Collection
Natural Science Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
Technology Collection
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef


MEDLINE - Academic
Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer_OA刊
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 16
ExternalDocumentID oai_doaj_org_article_79c3134ea4b5420cb29a8b3a084dbf18
10_1038_s41467_023_43447_0
38086794
Genre Journal Article
GrantInformation_xml – fundername: Manatu Hauora | Health Research Council of New Zealand (HRC)
  funderid: https://doi.org/10.13039/501100001505
– fundername: Royal Society Te Apārangi 11 Turnbull St Thorndon, Wellington 6011 Aotearoa - New Zealand
– fundername: Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID)
  funderid: https://doi.org/10.13039/100006492
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADRAZ
AENEX
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LGEZI
LK8
LOTEE
M1P
M48
M7P
M~E
NADUK
NAO
NXXTH
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PQEST
PQUKI
RC3
SOI
7X8
5PM
ID FETCH-LOGICAL-c541t-9a4a06689306a44f21d8e72652d282f41f804ee1abd0f25f0e2590651132cbb03
IEDL.DBID RPM
ISSN 2041-1723
IngestDate Tue Dec 17 15:19:19 EST 2024
Tue Sep 17 21:29:15 EDT 2024
Wed Oct 16 17:22:32 EDT 2024
Fri Nov 08 20:56:47 EST 2024
Thu Nov 21 23:30:00 EST 2024
Sat Nov 02 12:29:18 EDT 2024
Fri Oct 11 20:48:08 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c541t-9a4a06689306a44f21d8e72652d282f41f804ee1abd0f25f0e2590651132cbb03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7053-2895
0000-0001-7571-9253
0000-0002-4839-9386
0000-0003-1238-1552
0000-0001-5465-8113
0000-0002-6544-5268
0000-0003-1245-4459
0000-0003-2140-6205
0000-0002-0311-3233
0000-0001-9993-1347
0000-0003-4301-4640
0000-0002-5354-9270
0000-0001-7360-1809
0000-0002-9817-3852
0009-0001-0793-1049
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10716133/
PMID 38086794
PQID 2900963338
PQPubID 546298
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_79c3134ea4b5420cb29a8b3a084dbf18
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10716133
proquest_miscellaneous_2902933728
proquest_journals_2900963338
crossref_primary_10_1038_s41467_023_43447_0
pubmed_primary_38086794
springer_journals_10_1038_s41467_023_43447_0
PublicationCentury 2000
PublicationDate 2023-12-12
PublicationDateYYYYMMDD 2023-12-12
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-12
  day: 12
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2023
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – sequence: 0
  name: Nature Portfolio
– name: Nature Publishing Group UK
– name: Nature Publishing Group
References Freyne (CR88) 2020; 221
van Laarhoven (CR27) 2021; 2
CR39
CR36
CR35
Mahauad-Fernandez, Okeoma (CR57) 2016; 4
CR33
Hou (CR5) 2020; 182
CR31
Glineur (CR19) 2014; 468-470
Kaveh, Garcia-Pelayo, Hogarth (CR86) 2014; 32
Nguyen, Ait Hamou, Gastli, Chapuis, Pene (CR28) 2021; 47
Blackwell, Christman (CR75) 1997; 17
Newport (CR68) 1996; 335
Bessiere (CR30) 2021; 17
Sefik (CR52) 2022; 606
Chong (CR10) 2022; 39
Sun (CR63) 2020; 182
Wang (CR103) 2012; 14
CR42
Holmes, Stanford (CR55) 2007; 25
Weiss (CR26) 2010; 30
Rusinova (CR16) 2013; 41
Ladel (CR45) 1995; 25
Blossey (CR79) 2023; 76
Bogdan (CR15) 2001; 2
Messina (CR74) 2022; 11
Reed, Muench (CR95) 1938; 27
Wang (CR43) 2021; 54
Hoffmann (CR2) 2020; 181
Galani (CR59) 2021; 22
Crotta (CR7) 2013; 9
CR53
Garcia-Diaz (CR58) 2017; 19
CR50
Ziegler (CR4) 2020; 181
Frieman (CR20) 2010; 6
Kamijo (CR46) 1993; 178
Singh (CR34) 2023; 26
Dinnon (CR70) 2020; 586
Counoupas (CR77) 2021; 6
Minassian (CR87) 2012; 205
Song (CR90) 2021; 8
Moriyama, Lucas, Monteiro, Yale, Iwasaki (CR61) 2023; 120
CR66
CR64
CR60
Li (CR40) 2021; 184
Reis (CR32) 2023; 388
Makris, Paulsen, Johansson, Type (CR8) 2017; 8
Zhou (CR1) 2020; 579
Pfaender (CR49) 2020; 5
Martin-Sancho (CR48) 2021; 81
Schoggins (CR6) 2019; 6
Pan (CR41) 2021; 6
(CR91) 2021; 73
Eichinger (CR24) 2015; 16
Santos (CR85) 2023; 130
Rottman (CR51) 2008; 5
CR9
Zhang (CR44) 2022; 13
CR89
Borcherding (CR102) 2021; 4
Claus (CR81) 2023; 14
CR83
Hao (CR97) 2021; 184
Hildebrand (CR38) 2022; 10
Kaufmann (CR71) 2022; 38
Leist (CR69) 2020; 183
Jouanguy (CR67) 1996; 335
O’Brien (CR13) 2020; 71
Keir, Butte, Freeman, Sharpe (CR54) 2008; 26
Hadjadj (CR11) 2020; 369
Pittet (CR82) 2023; 388
Florez (CR72) 2020; 33
Hilligan, Namasivayam, Sher (CR76) 2023; 14
Neil, Zang, Bieniasz (CR56) 2008; 451
CR12
Califano (CR21) 2018; 11
CR99
CR98
CR96
Muus (CR3) 2021; 27
CR94
Graham (CR17) 1993; 178
CR93
CR92
Bot, Bot, Bona (CR18) 1998; 72
Hayn (CR62) 2021; 35
Ogger (CR14) 2022; 52
Dos Anjos (CR84) 2022; 13
Liu (CR23) 2004; 40
Ten Doesschate (CR80) 2022; 28
Rosas Mejia (CR37) 2022; 18
CR29
Winkler (CR47) 2020; 21
CR25
CR104
CR105
Dorman (CR65) 1999; 135
CR100
CR101
Moorlag (CR78) 2022; 75
Yamamoto, Shibamori, Ogura, Seko, Kikuchi (CR22) 1998; 97
Stifter (CR73) 2019; 29
I Rusinova (43447_CR16) 2013; 41
S Pfaender (43447_CR49) 2020; 5
P Bessiere (43447_CR30) 2021; 17
WM Song (43447_CR90) 2021; 8
43447_CR50
SA Stifter (43447_CR73) 2019; 29
Q Li (43447_CR40) 2021; 184
AK Singh (43447_CR34) 2023; 26
43447_CR53
LS Nguyen (43447_CR28) 2021; 47
C Zhang (43447_CR44) 2022; 13
KL Hilligan (43447_CR76) 2023; 14
43447_CR105
C Bogdan (43447_CR15) 2001; 2
M Rottman (43447_CR51) 2008; 5
NL Messina (43447_CR74) 2022; 11
SE Dorman (43447_CR65) 1999; 135
TS Blackwell (43447_CR75) 1997; 17
T Ten Doesschate (43447_CR80) 2022; 28
AP Santos (43447_CR85) 2023; 130
43447_CR60
N Borcherding (43447_CR102) 2021; 4
43447_CR66
43447_CR64
E Jouanguy (43447_CR67) 1996; 335
SF Glineur (43447_CR19) 2014; 468-470
G Liu (43447_CR23) 2004; 40
Y Hao (43447_CR97) 2021; 184
MB Frieman (43447_CR20) 2010; 6
C Muus (43447_CR3) 2021; 27
SJ Neil (43447_CR56) 2008; 451
LJ Reed (43447_CR95) 1938; 27
MB Graham (43447_CR17) 1993; 178
43447_CR33
43447_CR31
F Wang (43447_CR103) 2012; 14
M Hoffmann (43447_CR2) 2020; 181
43447_CR36
43447_CR35
CGK Ziegler (43447_CR4) 2020; 181
43447_CR39
LRB Dos Anjos (43447_CR84) 2022; 13
C Holmes (43447_CR55) 2007; 25
E Sefik (43447_CR52) 2022; 606
P Zhou (43447_CR1) 2020; 579
N Yamamoto (43447_CR22) 1998; 97
AM Blossey (43447_CR79) 2023; 76
J Hadjadj (43447_CR11) 2020; 369
MJ Newport (43447_CR68) 1996; 335
A Bot (43447_CR18) 1998; 72
43447_CR42
J Sun (43447_CR63) 2020; 182
TR O’Brien (43447_CR13) 2020; 71
AM Minassian (43447_CR87) 2012; 205
DA Kaveh (43447_CR86) 2014; 32
PP Ogger (43447_CR14) 2022; 52
L Martin-Sancho (43447_CR48) 2021; 81
43447_CR92
43447_CR96
43447_CR94
KM Eichinger (43447_CR24) 2015; 16
O Rosas Mejia (43447_CR37) 2022; 18
RE Hildebrand (43447_CR38) 2022; 10
IE Galani (43447_CR59) 2021; 22
43447_CR93
43447_CR12
LF Pittet (43447_CR82) 2023; 388
43447_CR99
S Moorlag (43447_CR78) 2022; 75
43447_CR98
M Hayn (43447_CR62) 2021; 35
S Crotta (43447_CR7) 2013; 9
ID Weiss (43447_CR26) 2010; 30
B Freyne (43447_CR88) 2020; 221
43447_CR9
ME Keir (43447_CR54) 2008; 26
SR Leist (43447_CR69) 2020; 183
43447_CR25
ES Winkler (43447_CR47) 2020; 21
A Garcia-Diaz (43447_CR58) 2017; 19
43447_CR29
D Califano (43447_CR21) 2018; 11
A van Laarhoven (43447_CR27) 2021; 2
WD Mahauad-Fernandez (43447_CR57) 2016; 4
JW Schoggins (43447_CR6) 2019; 6
M Moriyama (43447_CR61) 2023; 120
R Wang (43447_CR43) 2021; 54
T Pan (43447_CR41) 2021; 6
C Counoupas (43447_CR77) 2021; 6
Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, S.A. (43447_CR91) 2021; 73
43447_CR100
43447_CR104
43447_CR101
R Kamijo (43447_CR46) 1993; 178
CH Ladel (43447_CR45) 1995; 25
E Kaufmann (43447_CR71) 2022; 38
J Claus (43447_CR81) 2023; 14
43447_CR83
S Makris (43447_CR8) 2017; 8
Z Chong (43447_CR10) 2022; 39
KH Dinnon 3rd (43447_CR70) 2020; 586
MA Florez (43447_CR72) 2020; 33
43447_CR89
G Reis (43447_CR32) 2023; 388
YJ Hou (43447_CR5) 2020; 182
References_xml – volume: 4
  start-page: 122
  year: 2021
  ident: CR102
  article-title: Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
  publication-title: Commun. Biol.
  doi: 10.1038/s42003-020-01625-6
  contributor:
    fullname: Borcherding
– volume: 47
  start-page: 619
  year: 2021
  end-page: 621
  ident: CR28
  article-title: Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesis
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-021-06377-3
  contributor:
    fullname: Pene
– volume: 5
  start-page: e26
  year: 2008
  ident: CR51
  article-title: IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.0050026
  contributor:
    fullname: Rottman
– volume: 2
  start-page: 907
  year: 2001
  end-page: 916
  ident: CR15
  article-title: Nitric oxide and the immune response
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1001-907
  contributor:
    fullname: Bogdan
– ident: CR39
– volume: 54
  start-page: 1611
  year: 2021
  end-page: 1621 e1615
  ident: CR43
  article-title: Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
  publication-title: Immunity
  doi: 10.1016/j.immuni.2021.06.003
  contributor:
    fullname: Wang
– ident: CR25
– ident: CR42
– ident: CR101
– volume: 182
  start-page: 429
  year: 2020
  end-page: 446 e414
  ident: CR5
  article-title: SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract
  publication-title: Cell
  doi: 10.1016/j.cell.2020.05.042
  contributor:
    fullname: Hou
– volume: 28
  start-page: 1278
  year: 2022
  end-page: 1285
  ident: CR80
  article-title: Bacillus Calmette-Guerin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1016/j.cmi.2022.04.009
  contributor:
    fullname: Ten Doesschate
– volume: 8
  start-page: 259
  year: 2017
  ident: CR8
  article-title: Interferons as regulators of lung inflammation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2017.00259
  contributor:
    fullname: Type
– ident: CR92
– volume: 72
  start-page: 6637
  year: 1998
  end-page: 6645
  ident: CR18
  article-title: Protective role of gamma interferon during the recall response to influenza virus
  publication-title: J. Virol.
  doi: 10.1128/JVI.72.8.6637-6645.1998
  contributor:
    fullname: Bona
– volume: 181
  start-page: 1016
  year: 2020
  end-page: 1035 e1019
  ident: CR4
  article-title: SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues
  publication-title: Cell
  doi: 10.1016/j.cell.2020.04.035
  contributor:
    fullname: Ziegler
– volume: 388
  start-page: 1582
  year: 2023
  end-page: 1596
  ident: CR82
  article-title: Randomized trial of BCG vaccine to protect against Covid-19 in health care workers
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2212616
  contributor:
    fullname: Pittet
– volume: 18
  start-page: e1010093
  year: 2022
  ident: CR37
  article-title: Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1010093
  contributor:
    fullname: Rosas Mejia
– volume: 10
  start-page: e0307522
  year: 2022
  ident: CR38
  article-title: Superinfection with SARS-CoV-2 has deleterious effects on mycobacterium bovis BCG immunity and promotes dissemination of mycobacterium tuberculosis
  publication-title: Microbiol. Spectr.
  doi: 10.1128/spectrum.03075-22
  contributor:
    fullname: Hildebrand
– volume: 27
  start-page: 493
  year: 1938
  end-page: 497
  ident: CR95
  article-title: A simple method of estimating fifty per cent endpoints12
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/oxfordjournals.aje.a118408
  contributor:
    fullname: Muench
– ident: CR60
– volume: 73
  start-page: e2005
  year: 2021
  end-page: e2015
  ident: CR91
  article-title: Risk factors for coronavirus disease 2019 (COVID-19) death in a population Cohort Study from the Western Cape Province, South Africa
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa1198
– ident: CR36
– volume: 120
  start-page: e2221652120
  year: 2023
  ident: CR61
  article-title: Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.2221652120
  contributor:
    fullname: Iwasaki
– volume: 586
  start-page: 560
  year: 2020
  end-page: 566
  ident: CR70
  article-title: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
  publication-title: Nature
  doi: 10.1038/s41586-020-2708-8
  contributor:
    fullname: Dinnon
– volume: 182
  start-page: 734
  year: 2020
  end-page: 743 e735
  ident: CR63
  article-title: Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment
  publication-title: Cell
  doi: 10.1016/j.cell.2020.06.010
  contributor:
    fullname: Sun
– volume: 29
  start-page: 3539
  year: 2019
  end-page: 3550 e3534
  ident: CR73
  article-title: Visualizing the selectivity and dynamics of interferon signaling in vivo
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2019.11.021
  contributor:
    fullname: Stifter
– volume: 178
  start-page: 1725
  year: 1993
  end-page: 1732
  ident: CR17
  article-title: Response to influenza infection in mice with a targeted disruption in the interferon gamma gene
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.178.5.1725
  contributor:
    fullname: Graham
– volume: 14
  start-page: 22
  year: 2012
  end-page: 29
  ident: CR103
  article-title: RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues
  publication-title: J. Mol. Diagn.
  doi: 10.1016/j.jmoldx.2011.08.002
  contributor:
    fullname: Wang
– ident: CR100
– volume: 26
  start-page: 107733
  year: 2023
  ident: CR34
  article-title: Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells
  publication-title: iScience
  doi: 10.1016/j.isci.2023.107733
  contributor:
    fullname: Singh
– ident: CR66
– volume: 221
  start-page: 1999
  year: 2020
  end-page: 2009
  ident: CR88
  article-title: Neonatal BCG vaccination reduces interferon-gamma responsiveness to heterologous pathogens in infants from a randomized controlled trial
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiaa030
  contributor:
    fullname: Freyne
– volume: 71
  start-page: 1410
  year: 2020
  end-page: 1412
  ident: CR13
  article-title: Weak induction of interferon expression by severe acute respiratory syndrome coronavirus 2 supports clinical trials of interferon-lambda to treat early coronavirus disease 2019
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa453
  contributor:
    fullname: O’Brien
– volume: 11
  start-page: e1387
  year: 2022
  ident: CR74
  article-title: Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19
  publication-title: Clin. Transl. Immunol.
  doi: 10.1002/cti2.1387
  contributor:
    fullname: Messina
– ident: CR89
– volume: 9
  start-page: e1003773
  year: 2013
  ident: CR7
  article-title: Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1003773
  contributor:
    fullname: Crotta
– volume: 26
  start-page: 677
  year: 2008
  end-page: 704
  ident: CR54
  article-title: PD-1 and its ligands in tolerance and immunity
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.26.021607.090331
  contributor:
    fullname: Sharpe
– volume: 181
  start-page: 271
  year: 2020
  end-page: 280 e278
  ident: CR2
  article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.052
  contributor:
    fullname: Hoffmann
– volume: 13
  start-page: 841868
  year: 2022
  ident: CR84
  article-title: Efficacy and safety of BCG revaccination With M. bovis BCG Moscow to prevent COVID-19 infection in health care workers: a randomized phase II clinical trial
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2022.841868
  contributor:
    fullname: Dos Anjos
– volume: 41
  start-page: D1040
  year: 2013
  end-page: D1046
  ident: CR16
  article-title: Interferome v2.0: an updated database of annotated interferon-regulated genes
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gks1215
  contributor:
    fullname: Rusinova
– ident: CR33
– volume: 81
  start-page: 2656
  year: 2021
  end-page: 2668.e8
  ident: CR48
  article-title: Functional landscape of SARS-CoV-2 cellular restriction
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2021.04.008
  contributor:
    fullname: Martin-Sancho
– volume: 8
  start-page: 657006
  year: 2021
  ident: CR90
  article-title: COVID-19 and tuberculosis coinfection: an overview of case reports/case series and meta-analysis
  publication-title: Front. Med. (Lausanne)
  doi: 10.3389/fmed.2021.657006
  contributor:
    fullname: Song
– volume: 40
  start-page: 201
  year: 2004
  end-page: 206
  ident: CR23
  article-title: Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma
  publication-title: FEMS Immunol. Med. Microbiol.
  doi: 10.1016/S0928-8244(03)00358-4
  contributor:
    fullname: Liu
– volume: 39
  start-page: 110799
  year: 2022
  ident: CR10
  article-title: Nasally delivered interferon-lambda protects mice against infection by SARS-CoV-2 variants including Omicron
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2022.110799
  contributor:
    fullname: Chong
– volume: 388
  start-page: 518
  year: 2023
  end-page: 528
  ident: CR32
  article-title: Early treatment with pegylated interferon lambda for Covid-19
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2209760
  contributor:
    fullname: Reis
– volume: 184
  start-page: 3573
  year: 2021
  end-page: 3587 e3529
  ident: CR97
  article-title: Integrated analysis of multimodal single-cell data
  publication-title: Cell
  doi: 10.1016/j.cell.2021.04.048
  contributor:
    fullname: Hao
– ident: CR94
– volume: 6
  start-page: e1000849
  year: 2010
  ident: CR20
  article-title: SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1000849
  contributor:
    fullname: Frieman
– volume: 17
  start-page: 3
  year: 1997
  end-page: 9
  ident: CR75
  article-title: The role of nuclear factor-kappa B in cytokine gene regulation
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/ajrcmb.17.1.f132
  contributor:
    fullname: Christman
– volume: 6
  start-page: 567
  year: 2019
  end-page: 584
  ident: CR6
  article-title: Interferon-stimulated genes: what do they all do?
  publication-title: Annu. Rev. Virol.
  doi: 10.1146/annurev-virology-092818-015756
  contributor:
    fullname: Schoggins
– volume: 335
  start-page: 1956
  year: 1996
  end-page: 1961
  ident: CR67
  article-title: Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199612263352604
  contributor:
    fullname: Jouanguy
– volume: 135
  start-page: 640
  year: 1999
  end-page: 643
  ident: CR65
  article-title: Viral infections in interferon-gamma receptor deficiency
  publication-title: J. Pediatr.
  doi: 10.1016/S0022-3476(99)70064-8
  contributor:
    fullname: Dorman
– volume: 14
  start-page: 1232764
  year: 2023
  ident: CR76
  article-title: BCG mediated protection of the lung against experimental SARS-CoV-2 infection
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2023.1232764
  contributor:
    fullname: Sher
– ident: CR83
– volume: 75
  start-page: e938
  year: 2022
  end-page: e946
  ident: CR78
  article-title: Efficacy of BCG vaccination against respiratory tract infections in older adults during the coronavirus disease 2019 pandemic
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciac182
  contributor:
    fullname: Moorlag
– volume: 17
  start-page: e1009427
  year: 2021
  ident: CR30
  article-title: Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1009427
  contributor:
    fullname: Bessiere
– volume: 25
  start-page: 838
  year: 1995
  end-page: 846
  ident: CR45
  article-title: Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: studies with T cell receptor-deficient mutant mice
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.1830250331
  contributor:
    fullname: Ladel
– volume: 13
  start-page: 869809
  year: 2022
  ident: CR44
  article-title: The SARS-CoV-2 B.1.351 variant can transmit in rats but not in mice
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2022.869809
  contributor:
    fullname: Zhang
– ident: CR93
– volume: 205
  start-page: 1035
  year: 2012
  end-page: 1042
  ident: CR87
  article-title: A human challenge model for mycobacterium tuberculosis using mycobacterium bovis bacille Calmette-Guerin
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jis012
  contributor:
    fullname: Minassian
– ident: CR12
– volume: 2
  start-page: 1163
  year: 2021
  end-page: 1170 e1162
  ident: CR27
  article-title: Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: a case series
  publication-title: Med
  doi: 10.1016/j.medj.2021.09.003
  contributor:
    fullname: van Laarhoven
– volume: 579
  start-page: 270
  year: 2020
  end-page: 273
  ident: CR1
  article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin
  publication-title: Nature
  doi: 10.1038/s41586-020-2012-7
  contributor:
    fullname: Zhou
– ident: CR35
– volume: 468-470
  start-page: 140
  year: 2014
  end-page: 149
  ident: CR19
  article-title: Sustained inflammation and differential expression of interferons type I and III in PVM-infected interferon-gamma (IFNgamma) gene-deleted mice
  publication-title: Virology
  doi: 10.1016/j.virol.2014.07.039
  contributor:
    fullname: Glineur
– ident: CR29
– volume: 606
  start-page: 585
  year: 2022
  end-page: 593
  ident: CR52
  article-title: Inflammasome activation in infected macrophages drives COVID-19 pathology
  publication-title: Nature
  doi: 10.1038/s41586-022-04802-1
  contributor:
    fullname: Sefik
– volume: 4
  start-page: 4
  year: 2016
  end-page: 23
  ident: CR57
  article-title: The role of BST-2/Tetherin in host protection and disease manifestation
  publication-title: Immun. Inflamm. Dis.
  doi: 10.1002/iid3.92
  contributor:
    fullname: Okeoma
– volume: 184
  start-page: 2362
  year: 2021
  end-page: 2371.e9
  ident: CR40
  article-title: SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
  publication-title: Cell
  doi: 10.1016/j.cell.2021.02.042
  contributor:
    fullname: Li
– volume: 14
  start-page: e0035623
  year: 2023
  ident: CR81
  article-title: BCG vaccination of health care workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomized placebo-controlled trial
  publication-title: mBio
  doi: 10.1128/mbio.00356-23
  contributor:
    fullname: Claus
– volume: 16
  start-page: 122
  year: 2015
  ident: CR24
  article-title: Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice
  publication-title: Respir. Res.
  doi: 10.1186/s12931-015-0282-7
  contributor:
    fullname: Eichinger
– volume: 97
  start-page: 1017
  year: 1998
  end-page: 1023
  ident: CR22
  article-title: Effects of intranasal administration of recombinant murine interferon-gamma on murine acute myocarditis caused by encephalomyocarditis virus
  publication-title: Circulation
  doi: 10.1161/01.CIR.97.10.1017
  contributor:
    fullname: Kikuchi
– ident: CR96
– volume: 178
  start-page: 1435
  year: 1993
  end-page: 1440
  ident: CR46
  article-title: Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.178.4.1435
  contributor:
    fullname: Kamijo
– volume: 25
  start-page: 1339
  year: 2007
  end-page: 1347
  ident: CR55
  article-title: Concise review: stem cell antigen-1: expression, function, and enigma
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2006-0644
  contributor:
    fullname: Stanford
– ident: CR50
– volume: 335
  start-page: 1941
  year: 1996
  end-page: 1949
  ident: CR68
  article-title: A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199612263352602
  contributor:
    fullname: Newport
– volume: 21
  start-page: 1327
  year: 2020
  end-page: 1335
  ident: CR47
  article-title: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-020-0778-2
  contributor:
    fullname: Winkler
– volume: 52
  start-page: 1768
  year: 2022
  end-page: 1775
  ident: CR14
  article-title: Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.202249913
  contributor:
    fullname: Ogger
– ident: CR9
– ident: CR64
– volume: 27
  start-page: 546
  year: 2021
  end-page: 559
  ident: CR3
  article-title: Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-01227-z
  contributor:
    fullname: Muus
– ident: CR105
– ident: CR99
– volume: 35
  start-page: 109126
  year: 2021
  ident: CR62
  article-title: Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.109126
  contributor:
    fullname: Hayn
– volume: 19
  start-page: 1189
  year: 2017
  end-page: 1201
  ident: CR58
  article-title: Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2017.04.031
  contributor:
    fullname: Garcia-Diaz
– ident: CR53
– volume: 32
  start-page: 6911
  year: 2014
  end-page: 6918
  ident: CR86
  article-title: Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2014.10.041
  contributor:
    fullname: Hogarth
– ident: CR98
– volume: 6
  start-page: 420
  year: 2021
  ident: CR41
  article-title: Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/s41392-021-00848-1
  contributor:
    fullname: Pan
– ident: CR104
– volume: 451
  start-page: 425
  year: 2008
  end-page: 430
  ident: CR56
  article-title: Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
  publication-title: Nature
  doi: 10.1038/nature06553
  contributor:
    fullname: Bieniasz
– volume: 183
  start-page: 1070
  year: 2020
  end-page: 1085 e1012
  ident: CR69
  article-title: A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice
  publication-title: Cell
  doi: 10.1016/j.cell.2020.09.050
  contributor:
    fullname: Leist
– volume: 5
  start-page: 1330
  year: 2020
  end-page: 1339
  ident: CR49
  article-title: LY6E impairs coronavirus fusion and confers immune control of viral disease
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-020-0769-y
  contributor:
    fullname: Pfaender
– volume: 11
  start-page: 209
  year: 2018
  end-page: 219
  ident: CR21
  article-title: IFN-gamma increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells
  publication-title: Mucosal Immunol.
  doi: 10.1038/mi.2017.41
  contributor:
    fullname: Califano
– volume: 38
  start-page: 110502
  year: 2022
  ident: CR71
  article-title: BCG vaccination provides protection against IAV but not SARS-CoV-2
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2022.110502
  contributor:
    fullname: Kaufmann
– ident: CR31
– volume: 76
  start-page: 1304
  year: 2023
  end-page: 1310
  ident: CR79
  article-title: VPM1002 as prophylaxis against severe respiratory tract infections including coronavirus disease 2019 in the elderly: a phase 3 randomized, double-blind, placebo-controlled, multicenter clinical study
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciac881
  contributor:
    fullname: Blossey
– volume: 33
  start-page: 108530
  year: 2020
  ident: CR72
  article-title: Interferon gamma mediates hematopoietic stem cell activation and niche relocalization through BST2
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2020.108530
  contributor:
    fullname: Florez
– volume: 130
  start-page: 8
  year: 2023
  end-page: 16
  ident: CR85
  article-title: The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-the results of ProBCG: a multicenter randomized clinical trial in Brazil
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2023.02.014
  contributor:
    fullname: Santos
– volume: 30
  start-page: 439
  year: 2010
  end-page: 449
  ident: CR26
  article-title: IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner
  publication-title: J. Interferon Cytokine Res.
  doi: 10.1089/jir.2009.0084
  contributor:
    fullname: Weiss
– volume: 22
  start-page: 32
  year: 2021
  end-page: 40
  ident: CR59
  article-title: Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-020-00840-x
  contributor:
    fullname: Galani
– volume: 6
  year: 2021
  ident: CR77
  article-title: A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-021-00406-4
  contributor:
    fullname: Counoupas
– volume: 369
  start-page: 718
  year: 2020
  end-page: 724
  ident: CR11
  article-title: Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
  publication-title: Science
  doi: 10.1126/science.abc6027
  contributor:
    fullname: Hadjadj
– volume: 11
  start-page: e1387
  year: 2022
  ident: 43447_CR74
  publication-title: Clin. Transl. Immunol.
  doi: 10.1002/cti2.1387
  contributor:
    fullname: NL Messina
– volume: 17
  start-page: e1009427
  year: 2021
  ident: 43447_CR30
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1009427
  contributor:
    fullname: P Bessiere
– volume: 71
  start-page: 1410
  year: 2020
  ident: 43447_CR13
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa453
  contributor:
    fullname: TR O’Brien
– ident: 43447_CR39
  doi: 10.3389/fimmu.2023.1240419
– ident: 43447_CR9
  doi: 10.1084/jem.20201241
– volume: 21
  start-page: 1327
  year: 2020
  ident: 43447_CR47
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-020-0778-2
  contributor:
    fullname: ES Winkler
– ident: 43447_CR98
– volume: 22
  start-page: 32
  year: 2021
  ident: 43447_CR59
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-020-00840-x
  contributor:
    fullname: IE Galani
– volume: 579
  start-page: 270
  year: 2020
  ident: 43447_CR1
  publication-title: Nature
  doi: 10.1038/s41586-020-2012-7
  contributor:
    fullname: P Zhou
– volume: 205
  start-page: 1035
  year: 2012
  ident: 43447_CR87
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jis012
  contributor:
    fullname: AM Minassian
– volume: 26
  start-page: 677
  year: 2008
  ident: 43447_CR54
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.26.021607.090331
  contributor:
    fullname: ME Keir
– volume: 54
  start-page: 1611
  year: 2021
  ident: 43447_CR43
  publication-title: Immunity
  doi: 10.1016/j.immuni.2021.06.003
  contributor:
    fullname: R Wang
– volume: 30
  start-page: 439
  year: 2010
  ident: 43447_CR26
  publication-title: J. Interferon Cytokine Res.
  doi: 10.1089/jir.2009.0084
  contributor:
    fullname: ID Weiss
– volume: 183
  start-page: 1070
  year: 2020
  ident: 43447_CR69
  publication-title: Cell
  doi: 10.1016/j.cell.2020.09.050
  contributor:
    fullname: SR Leist
– volume: 8
  start-page: 657006
  year: 2021
  ident: 43447_CR90
  publication-title: Front. Med. (Lausanne)
  doi: 10.3389/fmed.2021.657006
  contributor:
    fullname: WM Song
– ident: 43447_CR31
  doi: 10.1084/jem.20211818
– volume: 75
  start-page: e938
  year: 2022
  ident: 43447_CR78
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciac182
  contributor:
    fullname: S Moorlag
– volume: 33
  start-page: 108530
  year: 2020
  ident: 43447_CR72
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2020.108530
  contributor:
    fullname: MA Florez
– ident: 43447_CR92
  doi: 10.1128/mBio.01928-20
– volume: 2
  start-page: 1163
  year: 2021
  ident: 43447_CR27
  publication-title: Med
  doi: 10.1016/j.medj.2021.09.003
  contributor:
    fullname: A van Laarhoven
– volume: 32
  start-page: 6911
  year: 2014
  ident: 43447_CR86
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2014.10.041
  contributor:
    fullname: DA Kaveh
– volume: 8
  start-page: 259
  year: 2017
  ident: 43447_CR8
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2017.00259
  contributor:
    fullname: S Makris
– volume: 16
  start-page: 122
  year: 2015
  ident: 43447_CR24
  publication-title: Respir. Res.
  doi: 10.1186/s12931-015-0282-7
  contributor:
    fullname: KM Eichinger
– volume: 17
  start-page: 3
  year: 1997
  ident: 43447_CR75
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/ajrcmb.17.1.f132
  contributor:
    fullname: TS Blackwell
– volume: 6
  year: 2021
  ident: 43447_CR77
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-021-00406-4
  contributor:
    fullname: C Counoupas
– ident: 43447_CR12
– volume: 130
  start-page: 8
  year: 2023
  ident: 43447_CR85
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2023.02.014
  contributor:
    fullname: AP Santos
– ident: 43447_CR99
  doi: 10.1007/978-3-319-24277-4
– volume: 468-470
  start-page: 140
  year: 2014
  ident: 43447_CR19
  publication-title: Virology
  doi: 10.1016/j.virol.2014.07.039
  contributor:
    fullname: SF Glineur
– ident: 43447_CR64
  doi: 10.1101/2022.09.13.507852
– ident: 43447_CR96
– volume: 5
  start-page: e26
  year: 2008
  ident: 43447_CR51
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.0050026
  contributor:
    fullname: M Rottman
– volume: 47
  start-page: 619
  year: 2021
  ident: 43447_CR28
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-021-06377-3
  contributor:
    fullname: LS Nguyen
– volume: 178
  start-page: 1725
  year: 1993
  ident: 43447_CR17
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.178.5.1725
  contributor:
    fullname: MB Graham
– volume: 181
  start-page: 271
  year: 2020
  ident: 43447_CR2
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.052
  contributor:
    fullname: M Hoffmann
– volume: 40
  start-page: 201
  year: 2004
  ident: 43447_CR23
  publication-title: FEMS Immunol. Med. Microbiol.
  doi: 10.1016/S0928-8244(03)00358-4
  contributor:
    fullname: G Liu
– volume: 586
  start-page: 560
  year: 2020
  ident: 43447_CR70
  publication-title: Nature
  doi: 10.1038/s41586-020-2708-8
  contributor:
    fullname: KH Dinnon 3rd
– volume: 178
  start-page: 1435
  year: 1993
  ident: 43447_CR46
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.178.4.1435
  contributor:
    fullname: R Kamijo
– volume: 606
  start-page: 585
  year: 2022
  ident: 43447_CR52
  publication-title: Nature
  doi: 10.1038/s41586-022-04802-1
  contributor:
    fullname: E Sefik
– volume: 25
  start-page: 1339
  year: 2007
  ident: 43447_CR55
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2006-0644
  contributor:
    fullname: C Holmes
– volume: 221
  start-page: 1999
  year: 2020
  ident: 43447_CR88
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiaa030
  contributor:
    fullname: B Freyne
– volume: 73
  start-page: e2005
  year: 2021
  ident: 43447_CR91
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa1198
  contributor:
    fullname: Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, S.A.
– volume: 72
  start-page: 6637
  year: 1998
  ident: 43447_CR18
  publication-title: J. Virol.
  doi: 10.1128/JVI.72.8.6637-6645.1998
  contributor:
    fullname: A Bot
– volume: 13
  start-page: 841868
  year: 2022
  ident: 43447_CR84
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2022.841868
  contributor:
    fullname: LRB Dos Anjos
– volume: 2
  start-page: 907
  year: 2001
  ident: 43447_CR15
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1001-907
  contributor:
    fullname: C Bogdan
– volume: 4
  start-page: 122
  year: 2021
  ident: 43447_CR102
  publication-title: Commun. Biol.
  doi: 10.1038/s42003-020-01625-6
  contributor:
    fullname: N Borcherding
– volume: 10
  start-page: e0307522
  year: 2022
  ident: 43447_CR38
  publication-title: Microbiol. Spectr.
  doi: 10.1128/spectrum.03075-22
  contributor:
    fullname: RE Hildebrand
– volume: 120
  start-page: e2221652120
  year: 2023
  ident: 43447_CR61
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.2221652120
  contributor:
    fullname: M Moriyama
– ident: 43447_CR89
  doi: 10.1172/jci.insight.159422
– volume: 28
  start-page: 1278
  year: 2022
  ident: 43447_CR80
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1016/j.cmi.2022.04.009
  contributor:
    fullname: T Ten Doesschate
– volume: 451
  start-page: 425
  year: 2008
  ident: 43447_CR56
  publication-title: Nature
  doi: 10.1038/nature06553
  contributor:
    fullname: SJ Neil
– volume: 182
  start-page: 429
  year: 2020
  ident: 43447_CR5
  publication-title: Cell
  doi: 10.1016/j.cell.2020.05.042
  contributor:
    fullname: YJ Hou
– volume: 9
  start-page: e1003773
  year: 2013
  ident: 43447_CR7
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1003773
  contributor:
    fullname: S Crotta
– ident: 43447_CR101
– volume: 388
  start-page: 1582
  year: 2023
  ident: 43447_CR82
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2212616
  contributor:
    fullname: LF Pittet
– volume: 26
  start-page: 107733
  year: 2023
  ident: 43447_CR34
  publication-title: iScience
  doi: 10.1016/j.isci.2023.107733
  contributor:
    fullname: AK Singh
– volume: 81
  start-page: 2656
  year: 2021
  ident: 43447_CR48
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2021.04.008
  contributor:
    fullname: L Martin-Sancho
– ident: 43447_CR104
– volume: 6
  start-page: e1000849
  year: 2010
  ident: 43447_CR20
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1000849
  contributor:
    fullname: MB Frieman
– volume: 184
  start-page: 2362
  year: 2021
  ident: 43447_CR40
  publication-title: Cell
  doi: 10.1016/j.cell.2021.02.042
  contributor:
    fullname: Q Li
– volume: 29
  start-page: 3539
  year: 2019
  ident: 43447_CR73
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2019.11.021
  contributor:
    fullname: SA Stifter
– volume: 335
  start-page: 1956
  year: 1996
  ident: 43447_CR67
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199612263352604
  contributor:
    fullname: E Jouanguy
– ident: 43447_CR33
  doi: 10.1084/jem.20211862
– ident: 43447_CR35
  doi: 10.1172/jci.insight.157393
– volume: 182
  start-page: 734
  year: 2020
  ident: 43447_CR63
  publication-title: Cell
  doi: 10.1016/j.cell.2020.06.010
  contributor:
    fullname: J Sun
– ident: 43447_CR53
– volume: 35
  start-page: 109126
  year: 2021
  ident: 43447_CR62
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.109126
  contributor:
    fullname: M Hayn
– volume: 39
  start-page: 110799
  year: 2022
  ident: 43447_CR10
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2022.110799
  contributor:
    fullname: Z Chong
– volume: 6
  start-page: 567
  year: 2019
  ident: 43447_CR6
  publication-title: Annu. Rev. Virol.
  doi: 10.1146/annurev-virology-092818-015756
  contributor:
    fullname: JW Schoggins
– ident: 43447_CR42
  doi: 10.3390/v14010027
– volume: 135
  start-page: 640
  year: 1999
  ident: 43447_CR65
  publication-title: J. Pediatr.
  doi: 10.1016/S0022-3476(99)70064-8
  contributor:
    fullname: SE Dorman
– volume: 76
  start-page: 1304
  year: 2023
  ident: 43447_CR79
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciac881
  contributor:
    fullname: AM Blossey
– ident: 43447_CR60
  doi: 10.1128/JVI.01410-20
– volume: 13
  start-page: 869809
  year: 2022
  ident: 43447_CR44
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2022.869809
  contributor:
    fullname: C Zhang
– volume: 5
  start-page: 1330
  year: 2020
  ident: 43447_CR49
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-020-0769-y
  contributor:
    fullname: S Pfaender
– volume: 14
  start-page: e0035623
  year: 2023
  ident: 43447_CR81
  publication-title: mBio
  doi: 10.1128/mbio.00356-23
  contributor:
    fullname: J Claus
– volume: 335
  start-page: 1941
  year: 1996
  ident: 43447_CR68
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199612263352602
  contributor:
    fullname: MJ Newport
– ident: 43447_CR83
– ident: 43447_CR25
  doi: 10.1084/jem.20220621
– volume: 6
  start-page: 420
  year: 2021
  ident: 43447_CR41
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/s41392-021-00848-1
  contributor:
    fullname: T Pan
– volume: 27
  start-page: 493
  year: 1938
  ident: 43447_CR95
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/oxfordjournals.aje.a118408
  contributor:
    fullname: LJ Reed
– volume: 14
  start-page: 22
  year: 2012
  ident: 43447_CR103
  publication-title: J. Mol. Diagn.
  doi: 10.1016/j.jmoldx.2011.08.002
  contributor:
    fullname: F Wang
– volume: 11
  start-page: 209
  year: 2018
  ident: 43447_CR21
  publication-title: Mucosal Immunol.
  doi: 10.1038/mi.2017.41
  contributor:
    fullname: D Califano
– volume: 41
  start-page: D1040
  year: 2013
  ident: 43447_CR16
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gks1215
  contributor:
    fullname: I Rusinova
– volume: 4
  start-page: 4
  year: 2016
  ident: 43447_CR57
  publication-title: Immun. Inflamm. Dis.
  doi: 10.1002/iid3.92
  contributor:
    fullname: WD Mahauad-Fernandez
– volume: 97
  start-page: 1017
  year: 1998
  ident: 43447_CR22
  publication-title: Circulation
  doi: 10.1161/01.CIR.97.10.1017
  contributor:
    fullname: N Yamamoto
– ident: 43447_CR94
  doi: 10.2807/1560-7917.ES.2020.25.3.2000045
– volume: 27
  start-page: 546
  year: 2021
  ident: 43447_CR3
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-01227-z
  contributor:
    fullname: C Muus
– ident: 43447_CR36
  doi: 10.1101/2023.07.31.551354
– ident: 43447_CR93
  doi: 10.1038/s41586-023-06322-y
– volume: 19
  start-page: 1189
  year: 2017
  ident: 43447_CR58
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2017.04.031
  contributor:
    fullname: A Garcia-Diaz
– ident: 43447_CR100
– ident: 43447_CR50
  doi: 10.1038/s41564-023-01431-w
– volume: 52
  start-page: 1768
  year: 2022
  ident: 43447_CR14
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.202249913
  contributor:
    fullname: PP Ogger
– volume: 18
  start-page: e1010093
  year: 2022
  ident: 43447_CR37
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1010093
  contributor:
    fullname: O Rosas Mejia
– volume: 369
  start-page: 718
  year: 2020
  ident: 43447_CR11
  publication-title: Science
  doi: 10.1126/science.abc6027
  contributor:
    fullname: J Hadjadj
– volume: 181
  start-page: 1016
  year: 2020
  ident: 43447_CR4
  publication-title: Cell
  doi: 10.1016/j.cell.2020.04.035
  contributor:
    fullname: CGK Ziegler
– volume: 14
  start-page: 1232764
  year: 2023
  ident: 43447_CR76
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2023.1232764
  contributor:
    fullname: KL Hilligan
– ident: 43447_CR29
  doi: 10.36233/0507-4088-24
– ident: 43447_CR66
– ident: 43447_CR105
– volume: 38
  start-page: 110502
  year: 2022
  ident: 43447_CR71
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2022.110502
  contributor:
    fullname: E Kaufmann
– volume: 388
  start-page: 518
  year: 2023
  ident: 43447_CR32
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2209760
  contributor:
    fullname: G Reis
– volume: 25
  start-page: 838
  year: 1995
  ident: 43447_CR45
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.1830250331
  contributor:
    fullname: CH Ladel
– volume: 184
  start-page: 3573
  year: 2021
  ident: 43447_CR97
  publication-title: Cell
  doi: 10.1016/j.cell.2021.04.048
  contributor:
    fullname: Y Hao
SSID ssj0000391844
Score 2.536815
Snippet Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral...
Abstract Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role of Type-2 IFN (IFNγ) in...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 8229
SubjectTerms 13/1
13/106
13/21
13/31
14/63
38/32
38/91
631/250/127/1212
631/326/596/2553
631/326/596/4130
64/60
Animal models
Animals
Antiviral agents
Bacteria
Bacterial diseases
Bacterial infections
Bronchopulmonary infection
COVID-19
COVID-19 - prevention & control
Epithelial cells
Epithelium
Hematopoietic stem cells
Humanities and Social Sciences
Immunity
Infections
Interferon
Interferon Type I - pharmacology
Interferon-gamma
Lung
Lungs
Mice
multidisciplinary
Pathogenesis
SARS-CoV-2
Science
Science (multidisciplinary)
Severe acute respiratory syndrome coronavirus 2
Viral diseases
γ-Interferon
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB4hpEpcqtLSNjwqI3FrLRw_EucIqAj1wIFHxc2yE7uttCSrZTnw7xnb2S3bFnFpjrEPo5mx_X3y-BuAg5YHRMlOUFV7QWXtJdWdY7QOolLOqih6Fastzquza_ntRt08afUVa8KyPHB23GHdtKIU0lvplOSsdbyx2gnLtOxcKPMzX8afkKm0B4sGqYscX8kwoQ_vZNoT8IiiMqrcUbZyEiXB_n-hzL-LJf-4MU0H0ekbeD0iSHKULd-ENd-_hVe5p-TDO5geZ_1lO6FItzFwHRlmZIoYGfe1yQOxo1pu7NFJoljELPjZ0JMf9vbWEmTHXS7iIogMyQS3AoKwlviog0zGunYyBHJ5dHFJT4bvlG_B9enXq5MzOrZVoK2S5Zw2VloEGghUWGWlDLzstK95pXiH_CvIMmgmvS-t61jgKjCPFAmRSuxJ3zrHxHtY74fefwRSBWRE1irHooy7xQ_POlWGzlXcN6Eq4PPCxWaa1TNMuvUW2uSAGAyISQExrIDjGIXlzKh8nX5gPpgxH8xL-VDA7iKGZlyOd4Y3kaoJpOMF7C-HcSHF2xHb--E-zUHoI2qOcz7kkC8tEZpFYUJZgF5JhhVTV0f6Xz-TWDfSawTVQhTwZZE3v-163hfb_8MXO7DBY8KXsX_NLqzPZ_d-DzHU3H1Ky-URmAoWzg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k1KQUbiBlYdPxLnhNqKpeLAgVLUm2Undou0TZbs9tB_3xnHu9XyyjH2wfE8_I1n8g0h71oRASV7yXQdJFN1UMx0nrM6ykp7p5H0CqstvlbHp-rLmT7LF27LXFa59onJUXdDi3fk-6JBtC0hovq4-MWwaxRmV3MLjbvkXinqCkv6zOzz5o4F2c-NUvlfGS7N_lIlzwAHFVPIdcf41nmUaPv_hjX_LJn8LW-ajqPZI_Iw40h6MAn-MbkT-ifk_tRZ8vopWRxOLMxuziDoBvF1dBjpApAyeLf5NXWZMxc7dVKkjBhjGIeenrvLS0chRu6mUi4K-JDOwSFQALc0IBsyzdXtdIj05ODbCTsafjDxjJzOPn0_Oma5uQJrtSpXrHHKAdwAuMIrp1QUZWdCLSotOojCoiqj4SqE0vmOR6EjDxAoAV7BzvSt91w-Jzv90IeXhFYR4iLntOdI5u7ggRNPl7HzlQhNrAryfr3FdjFxaNiU-5bGTgKxIBCbBGJ5QQ5RCpuZyH-dXgzjuc3mZOumlaVUwSmvleCtF40zXjpuVOdjaQqyt5ahzUa5tLcqVJC3m2EwJ8yRuD4MV2kOACBZC5jzYhL5ZiXScKQnVAUxW8qwtdTtkf7nRaLshiAboLWUBfmw1pvbdf17L3b__xmvyAOBqlxif5o9srMar8JrwEgr_yYZwg1n6Q5X
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1VRUhcEN-EFmQkbmBw_JE4B4TaiqpCggNlUW-Wndgt0jZZ0q3U_feMnWTRwkKOiSM5nhnPe_LkDcCrmgdEyU5QVXpBZekl1Y1jtAyiUM6qKHoVqy2-FCcz-elMne3A1O5oXMCrrdQu9pOa9fO3Nz9XHzDg3w-_jOt3VzKFO2YfKqOAHUUKf4tjZowlXp9HuJ92ZlEhoZHjvzPbX93IT0nGfxv2_LuE8o9z1JSeju_B3RFXkoPBEe7Djm8fwO2h0-TqISwOB1VmO6dIwtGcDel6skDkjLvdfEXsqKEbO3eSKCHRB993LTm3l5eWIGduhtIugniRzHGDIAh2iY_qyGSsdiddIKcHX0_pUfed8kcwO_747eiEjs0WaK1kvqSVlRbhB8IXVlgpA88b7UteKN4gKwsyD5pJ73PrGha4CswjcUL8EjvV184x8Rh22671T4EUAXmStcqxKO5u8cIMqPLQuIL7KhQZvJ6W2CwGTQ2TzsKFNoNBDBrEJIMYlsFhtMJ6ZNTDTje6_tyM4WXKqha5kN5KpyRnteOV1U5YpmXjQq4z2J9saCYfM7yKBE4gSc_g5foxhlc8M7Gt767TGAREouQ45slg8vVMhGZRrlBmoDecYWOqm0_aHxdJwhtJN0JtITJ4M_nN73n9ey2e_f8z9uAOj66cx341-7C77K_9c8RMS_ciBcIv1igRhQ
  priority: 102
  providerName: Scholars Portal
– databaseName: SpringerOpen
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwELVQERIXRPlMW5CRuIGFY48T59iuqCoOHChFvVl2YgPSNlltt4f-e2ac7KJAOZBj4kiWZybzXjx-w9jbViVEyUELU0ctoI4gbBekqJOuTPCGRK-o2uJzdXYBny7N5SSTQ2dhZvv32n64hhzKmFkEkDidQHp-H3NwTd68qBa7_ymkdG4BpnMxd786yz1Zov8uXPl3eeQfe6Q59Zw-Zo8mzMiPRyPvs3uxf8IejF0kb5-y1cmouOyXAgk2mqrjw5qvEBXjl2x5y_2kj0tdOTnJQ6xTXA89_-6vrjxHPtyNZVscsSBfYvBzBLI8kvIxnyrZ-ZD4-fGXc7EYvgn1jF2cfvy6OBNTIwXRGig3ovHgEVogNJGVB0iq7GysVWVUh4wrQZmshBhLHzqZlEkyIilCbEJd6NsQpH7O9vqhjy8ZrxJyIO9NkCTc7vHC7GbK1IVKxSZVBXu3XWK3GvUyXN7n1taNBnFoEJcN4mTBTsgKu5GkdZ1voAu4KXRc3bS61BA9BANKtkE13gbtpYUupNIW7GhrQzcF4LVTDZEzjQS8YG92jzF0aD_E93G4yWMQ7Oha4ZgXo8l3M9FWkhQhFMzOnGE21fmT_uePLM-NhBphtNYFe7_1m9_z-vdaHPzf8EP2UJFrl9Sb5ojtbdY38RXio014nQPjF0HsBzY
  priority: 102
  providerName: Springer Nature
Title Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2
URI https://link.springer.com/article/10.1038/s41467-023-43447-0
https://www.ncbi.nlm.nih.gov/pubmed/38086794
https://www.proquest.com/docview/2900963338
https://www.proquest.com/docview/2902933728
https://pubmed.ncbi.nlm.nih.gov/PMC10716133
https://doaj.org/article/79c3134ea4b5420cb29a8b3a084dbf18
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtx2AvY_e564IGe9vUyLrY8mMSmpVAS2nWkTcj2VJbSOzgpg_99z2S7WzZ5WV-sMEWWOgc6XyfdfwdhD4XzAFKNpzI1HIiUiuIKg0lqeOJNFp60SufbXGenF6J2UIu9lDS_wsTkvYLc3tcLVfH1e1NyK1cr4phnyc2vDibAGUBoML5cB_tQ_z9haOH9ZdnQFtE94cM5Wp4J8J6AOGJCK9wR3z9N66oF5sTOwEp6Pb_DWz-mTP528ZpiEfTF-h5ByTxqO3wS7Rnq1foaVta8uE1Wo9bGWa9JMC6wX4lrhu8BqgMy9vyAetONNeX6sReM6JxtqkrfK1XK42BJJdtLhcGgIiXsCJgQLfYejlk3KW349rh-ehyTib1D8LeoKvpyffJKemqK5BCinhDMi004A3AKzTRQjgWl8qmLJGsBBrmROwUFdbG2pTUMemoBaYEgMWXpi-MofwtOqjqyr5HOHEwlFpLQ72au4YDQp6MXWkSZjOXROhLP8T5uhXRyMPmN1d5a5scbJMH2-Q0QmNvhW1LL4AdbtTNdd65QZ5mBY-5sFoYKRgtDMu0MlxTJUrjYhWho96GeTcr73KWecbGgZVH6NP2Mcwnv0miK1vfhzaAgHjKoM271uTbnvQuEyG14ww7Xd19Ai4cNLt7l43Q195vfvbr32Nx-P9v-oCeMe_xsS9ec4QONs29_QgAamMGMGsWKZzV9NsAPRmNZvMZXMcn5xeXcHeSTAbh0wScz4QahNn1CEnSH0g
link.rule.ids 230,314,727,780,784,864,885,2102,2221,12056,12765,21388,24318,27924,27925,31719,31720,33373,33374,33744,33745,41120,42189,43310,43600,43805,51576,53791,53793,73745,74035,74302
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVgguiGcJFDASN7Dq-JHHCXWrVguUFeoD9WbZiV2QtsmS3R767xkn3q2WV46xD47n4W88k28A3lbcI0q2gqrcCSpzJ2lRW0ZzLzJljQqkV6HaYppNzuSnc3UeL9wWsaxy5RN7R123Vbgj3-VlQNsCI6oP8580dI0K2dXYQuM2bAXmdDWCrfHB9Ovx-pYl8J8XUsa_ZZgodhey9w14VFEZ2O4o2ziReuL-v6HNP4smf8uc9gfS4QO4H5Ek2RtE_xBuueYR3Bl6S14_hvl44GE2M4phNwqwJm1H5oiV0b_NromJrLmhVycJpBGdd13bkAtzeWkIRsn1UMxFECGSGboEgvCWuMCHTGJ9O2k9Odk7PqH77TfKn8DZ4cHp_oTG9gq0UjJd0tJIg4ADAQvLjJSep3Xhcp4pXmMc5mXqCyadS42tmefKM4ehEiKW0Ju-spaJpzBq2sY9A5J5jIyMUZYFOneDD555KvW1zbgrfZbAu9UW6_nAoqH77Lco9CAQjQLRvUA0S2AcpLCeGRiw-xdtd6GjQem8rEQqpDPSKslZZXlpCisMK2RtfVoksLOSoY5mudA3SpTAm_UwGlTIkpjGtVf9HIRAIuc4Z3sQ-XolqGOBoFAmUGwow8ZSN0eaH9970m4MsxFcC5HA-5Xe3Kzr33vx_P-f8RruTk6_HOmjj9PPL-AeD2qdhm41OzBadlfuJSKmpX0VzeIXzSsSqA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Jb9QwFH6CqUC9IHYCBYzEDaw6XrKcUKd0VBaNqpai3iw7sQvSNJlmpof-e54Tz1TDlmNiRY7f9j375XsAbyvuESVbQVXuBJW5k7SoLaO5F5myRgXSq1BtMc0OT-XnM3UW658Wsaxy5RN7R123Vdgj3-VlQNsCM6pdH8sijj5OPswvaeggFU5aYzuN27CFUZHxEWyND6ZHx-sdl8CFXkgZ_5xh-KKF7P0Ehi0qA_MdZRvRqSfx_xvy_LOA8rdT1D44Te7DvYgqyd6gBg_glmsewp2hz-T1I5iPB05mM6OYgqMwa9J2ZI64GX3d7JqYyKAb-naSQCDRede1DTk3FxeGYMZcD4VdBNEimaF7IAh1iQvcyCTWupPWk5O94xO6336n_DGcTg6-7R_S2GqBVkqmS1oaaRB8IHhhmZHS87QuXM4zxWvMybxMfcGkc6mxNfNceeYwbUL0EvrUV9Yy8QRGTdu4Z0Ayj1mSMcqyQO1u8ML4p1Jf24y70mcJvFstsZ4PjBq6PwkXhR4EolEguheIZgmMgxTWIwMbdn-j7c51NC6dl5VIhXRGWiU5qywvTWGFYYWsrU-LBHZWMtTRRBf6RqESeLN-jMYVTkxM49qrfgzCIZFzHPN0EPl6JqJggaxQJlBsKMPGVDefND9_9ATemHIj0BYigfcrvbmZ17_X4vn_P-M13EWL0F8_Tb-8gG0etDoNjWt2YLTsrtxLBE9L-ypaxS-4dBbV
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bacterial-induced+or+passively+administered+interferon+gamma+conditions+the+lung+for+early+control+of+SARS-CoV-2&rft.jtitle=Nature+communications&rft.au=Hilligan%2C+Kerry+L&rft.au=Namasivayam%2C+Sivaranjani&rft.au=Clancy%2C+Chad+S&rft.au=Baker%2C+Paul+J&rft.date=2023-12-12&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=14&rft.issue=1&rft.spage=8229&rft_id=info:doi/10.1038%2Fs41467-023-43447-0&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon